Formulation Patents and Dermatology and Obviousness
Most patents covering dermatologic products contain patent claims directed to the pharmaceutical formulation of the product. Such patents, known as formulation patents, are vulnerable to attacks based on the legal argument that the formulations covered are obvious over formulations already known pri...
Main Authors: | Josephine Liu, Michael A. Davitz, Dan-Feng Mei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/3/4/914/ |
Similar Items
-
IMPLICATIONS FOR THE INVENTIVE STEP UNDER THE EUROPEAN PATENT CONVENTION RELATED TO THE INCREASING APPLICATION OF ARTIFICIAL INTELLIGENCE AND CERTIFICATION AS A SUI GENERIS PROTECTION MECHANISM FOR CREATIONS INVOLVING ARTIFICIAL INTELLIGENCE
by: Liva Rudzite
Published: (2023-06-01) -
SEMANTIC AND PRAGMATIC FEATURES OF OBVIOUSLY AND APPARENTLY
by: Jelena Šajinović Novaković, et al.
Published: (2023-06-01) -
美國專利法非顯而易知性之新觀點:相同條件下的客觀指標 A New Insight on the Non-obviousness of U.S. Patent Law: The Objective Indicia Under the Same Conditions
by: 劉懿嫻 Yi-Hsien Liu
Published: (2010-12-01) -
Isolated Meniscal Ramp Lesion Without Obvious Anterior Cruicate Ligament Rupture
by: Jun Jiang, et al.
Published: (2021-04-01) -
An Emulsion-Based Formulation for Increasing the Resistance of Plants to Salinity Stress: US20160302416A1 Patent Evaluation
by: Fatima Zahra Hafiane, et al.
Published: (2022-06-01)